IGF1R and breast carcinoma: This growing need to identify novel targets inhibiting resistance to anti-breast cancer agents has made IGF-1R a potential candidate.79, 80 Data have shown the upregulation of IGF-1R as an alternative pathway utilized by breast cancer cells to escape the consequences of chronic exposure to different therapeutics.